This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Corteva, Inc. provides agriculture products. The company develops and supplies germplasm and traits in corn, soybean and sunflower seed markets. It also supplies products to the agricultural input industry which protect against weeds, insects and other pests, and diseases as well as to enhance crop health. Corteva, Inc. is based in Wilmington, Delaware.
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, Campbell Soup, Celsius Holdings, Corteva and Hershey's
by Zacks Equity Research
Archer-Daniels-Midland, Campbell Soup, Celsius Holdings, Corteva and Hershey's are included in this Analyst Blog.
Top 5 High-Flying Consumer Staples Stocks With More Upside
by Nalak Das
We have narrowed our search to five consumer staples stocks that have popped year to date with more potential for the rest of 2022. These are: HSY, CELH, CPB, ADM and CTVA.
Are Consumer Staples Stocks Lagging Corteva (CTVA) This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and General Mills (GIS) have performed compared to their sector so far this year.
Zacks.com featured highlights include Corteva, Clearwater Paper and Chevron
by Zacks Equity Research
Corteva, Clearwater Paper and Chevron are part of zacks Screen of the week article.
3 Stocks With Upgraded Broker Ratings Despite Tough Backdrop
by Swayta Shah
As brokers have a deeper understanding of the stocks, one must follow rating upgrades. We select Corteva (CTVA), Clearwater Paper (CLW) and Chevron (CVX) as these witness ratings upgrades.
Is Corteva (CTVA) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and General Mills (GIS) have performed compared to their sector so far this year.
Corteva, Inc. (CTVA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 11.56% and 1.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Tyson Foods (TSN) Queued for Q3 Earnings: Things to Consider
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter performance is likely to reflect gains from solid demand and improved operational execution. However, rising inflation might have been a headwind.
Alico (ALCO) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Alico (ALCO) delivered earnings and revenue surprises of -450% and 10.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods (BGS) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher product demand and a solid brand portfolio are likely to aid B&G Foods' (BGS) second-quarter 2022 results. However, cost inflation is a major headwind.
What's in Store for International Flavors' (IFF) Q2 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q2 performance is likely to reflect benefits from robust demand for home care and personal categories, while escalating costs might have been a spoilsport.
Factors Likely to Decide Nu Skin's (NUS) Fate in Q2 Earnings
by Zacks Equity Research
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of COVID-led headwinds in Mainland China, the ongoing conflict between Russia and Ukraine, and the global economic downturn.
Why Earnings Season Could Be Great for Corteva (CTVA)
by Zacks Equity Research
Corteva (CTVA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors to Influence Monster Beverage's (MNST) Q2 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) Q2 results are expected to reflect gains from strong consumer demand for energy drinks, innovation and product launches amid a high cost environment.
Should Vanguard MidCap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
What to Expect From Sprouts Farmers' (SFM) Q2 Earnings?
by Zacks Equity Research
Sprouts Farmers' (SFM) second-quarter results are likely to reflect the focus on product innovation, targeted marketing and creating a robust omni-channel experience.
Kellogg (K) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Kellogg's (K) second-quarter 2022 results are likely to reflect gains from the EMEA region's strength and the snacks business, whereas cost inflation is likely to have been a challenge.
Clorox (CLX) Readies for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2022 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated cost concerns are likely to have affected profits.
Should iShares Russell MidCap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Corteva, Inc. (CTVA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Is Molson Coors (TAP) Slated to Report Earnings Beat in Q2?
by Zacks Equity Research
Molson Coors' (TAP) Q2 results are expected to reflect gains from innovation and premiumization efforts, aiding the top line. Elevated marketing and supply-chain costs are likely to have ailed.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
by Zacks Equity Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as upsides.